Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AstraZeneca
Origin Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
UMC Utrecht
BeOne Medicines
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
AstraZeneca
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech